ART

5.

Strategic performance report underscores Global Fund successes but challenges remain for service delivery and coverage of key populations

15 Nov 2018
New report combining KPI and Strategy reporting is presented to the Board

The Global Fund has achieved its targets in resource mobilization (i.e. Fifth Replenishment) and in aligning its investments with country needs and national strategic plans.

This information is contained in a report on Strategic Performance Reporting prepared for the Board’s 40th meeting just completed in Geneva on 14-15 November.

1.

Results for the Global Fund partnership in 2017 reveal large increases in lives saved and people treated for HIV, TB and malaria

17 Sep 2018
Changes in methodology for calculating results contributed to the increases

The Global Fund has released its Results Report 2018, the first such report to use the revised methodology adopted by the Fund for tracking and reporting impact and results. The Results Report 2018 provides results for the year 2017.

4.

Tanzania's TB/HIV funding request to the Global Fund yields three grants

6 Mar 2018
Funding request identifies vulnerable groups for TB

Mainland Tanzania submitted a funding request for its HIV and TB components that resulted in the Global Fund Board approving three grants, including a TB/HIV grant to a civil society principal recipient (PR) –– AMREF Health Africa. The Ministry of Finance and Planning (MOFP) was awarded an HIV grant and a TB grant.

5.

Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says

9 Jan 2018
Matching funds requests sent back for iteration

Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.

1.

Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says

13 Dec 2017
The reason? “Limitations of budgets in the 2017-2019 allocations period”
GAC calls for urgent inter-agency discussions, with donor governments included

In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation

9.

Global Fund expresses concern over Benin’s plan to shift funds away from HIV and malaria towards an RSSH funding request

23 Oct 2017
Secretariat decides to leave program split decision open until the RSSH proposal is received
Size of salary incentives linked to grant performance ratings

When it reviewed the funding requests from Benin, the Grant Approvals Committee (GAC) and the Technical Review Panel (TRP) expressed serious concerns about what they perceived as gaps in Benin’s HIV and malaria programs – which, they said, were partly due to the decision of the country coordinating mechanism (CCM) to shift some of its allocation towards an RSSH funding request.

The original allocation for Benin was as follows:

5.

New ARV database being piloted in the EECA region

18 Apr 2017
Provides information on drug prices and purchases

A new database is being developed in Eastern Europe and Central Asia (EECA) containing information on antiretrovirals (ARVs) in use in 15 countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Poland, the Russian Federation, Tajikistan, Ukraine and Uzbekistan.

4.

Number of people receiving ART through programs supported by the Global Fund reaches 10 million

31 Jan 2017
Mid-2016 results reported

In the first half of 2016, through programs supported by the Global Fund, another 787,000 people were put on antiretroviral treatment (ART) for HIV, bringing the total to date to 10 million, a 9% increase over end-2015 results and a 17% increase over the number a year ago. Three countries account for 77% of the increase from six months ago: Kenya (52%), Tanzania (16%) and Mozambique (9%).

5.

Is ending AIDS by 2030 a realistic goal?, researchers ask

19 Sep 2016

In an article published in The Lancet, a group of researchers questions whether the goal of ending the AIDS epidemic by 2030 with current prevention approaches is realistic.

8.

Board approves funding to extend shortened grants

1 Aug 2016
$388 million awarded to grants in five countries

In July 2016, the Global Fund Board approved $388 million in funding for six shortened grants to allow them to continue to provide services from the original end date of their grants to the end of 2017. Of the $388 million, $383 million is new funding. It comes from the $700 million that the Finance and Operational Performance Committee said in March 2016 was available for portfolio optimization.

Páginas

Suscribirse a ART